Cognitive, neuroimaging, and pathological studies in a patient with Pick's disease

Annals of Neurology

Volumn 43, Issue 2, 1998, Pages 259-265

  Lieberman, Andrew P ^a   Trojanowski, John Q ^a   Lee, Virginia M Y ^a   Balin, Brian J ^b   Ding, Xin Shen ^a   Greenberg, Joel ^a   Morrison, Donald ^c   Reivich, Martin ^a   Grossman, Murray ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b Allegheny University   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN BLOOD FLOW; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; COMPREHENSION; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LANGUAGE ABILITY; MALE; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL;

AGED; AMYGDALA; ATROPHY; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; DEMENTIA; DENTATE GYRUS; FATAL OUTCOME; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROSCOPY, ELECTRON; NEUROFIBRILS; NEURONS; TAU PROTEINS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031887227     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410430218     Document Type: Article

References (17)

1. Pick A. Uber die Beziehungen der senilen Hirnatrophie zue Aphasie. Prager Med Wochenschr 1892;17:165-167
2. Graff-Radford NR, Damasio AR, Hyman BT. Progressive aphasia in a patient with Pick's disease. Neurology 1990;40: 423-429
3. Kamo H, McGeer P, Harrop R, et al. Positron emission tomography and histopathology in Pick's disease. Neurology 1987;37:439-445
4. Delacourte A, Robitaille Y, Sergeant N. Specific pathological tau protein variants characterize Pick's disease. J Neuropathol Exp Neurol 1996;55:159-168
5. Buee-Scherrer V, Hof PR, Buee L. Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol 1996;91:351-359
6. Grossman M, Carvell S, Stern MB, et al. Sentence comprehension in Parkinson's disease: the role of attention and memory. Brain Lang 1992;42:347-384
7. Grossman M, White-Devine T. Sentence comprehension in Alzheimer's disease. Brain Lang (In press)
8. Jones SC, Greenberg JH, Dann R, et al. Cerebral blood flow with the continuous infusion of oxygen-15 labeled water. J Cereb Blood Flow Metab 1985;5:565-575
9. Karp JS, Muehllehner G, Mankoff DA, et al. Continuous slice Penn-PET: a volume tomograph with volume imaging capacity. J Nucl Med 1990;31:617-627
10. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York: Thieme Medical Publishing, 1988
11. Schmidt ML, Huang R, Martin JA. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau. J Neuropathol Exp Neurol 1996;55:534-539
12. Shaw G, Chau V. Ubiquitin and microtubule-associated protein tau immunoreactivity each define distinct structures with differing distributions and solubility properties in Alzheimer brain. Proc Natl Acad Sci USA 1988;85:2854-2858
13. Mawal-Dewan M, Schmidt ML, Balin B. Identification of phosphorylation sites in PHFtau from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex. J Neuropathol Exp Neurol 1996;55:1051-1059
14. Holland AL, McBurney DH, Moossy J, Reinmuth OM. The dissolution of language in Pick's disease with neurofibrillary tangles: a case study. Brain Lang 1985;34:36-58
15. Just MA, Carpenter PA, Keller TA, et al. Brain activation modulated by sentence comprehension. Science 1996;274:114-116
16. Grossman M, Payer F, Onishi K, et al. Language comprehension and regional cerebral defects in frontotemporal degeneration and Alzheimer's disease. Neurology (In press)
17. Goedert M, Trojanowski JQ, Lee VM-Y. The neurofibrillary pathology of Alzheimer's disease. In: Prusiner SB, Rosenberg RN, Di Mauro S, Barchi RL, eds. The molecular and genetic basis of neurologic disease. Boston: Butterworth Heinemann, 1997:613-628